<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Bioresearch Online News</title>
    <description>News Articles</description>
    <link>http://www.bioresearchonline.com/</link>
    <pubdate>1/6/2009 10:00:00 AM</pubdate>
    <item>
      <title>Advaxis' Phase II Clinical Trial "HOLD" Lifted</title>
      <description>Advaxis Inc (OTCBB: ADXS), a biotechnology company, received permission from the U. S. Food and Drug Administration (FDA) to test its lead drug candidate, Lovaxin C, in patients with grade 2/3 cervical intraepithelial neoplasia (CIN). With this approval of the Investigational New Drug (IND) application for Lovaxin C, the FDA "HOLD" on Advaxis' clinical program has been lifted.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Advaxis-Phase-II-Clinical-Trial-HOLD-Lifted-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 10:00:00 AM</pubdate>
    </item>
    <item>
      <title>Cytori Expands Patent Protection for Celution® Stem &amp;amp; Regenerative Cell Processing System</title>
      <description>Cytori (NASDAQ: CYTX) today received U.S. Patent No. 7,473,420 (the '420 patent), which protects important formulations of the Celution® System output. This builds upon U.S. Patent No. 7,390,484, issued to Cytori in June 2008, which covers the Celution System technology for the bedside processing of stem and regenerative cells derived from adipose tissue.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Cytori-Expands-Patent-Protection-for-Celution-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 7:00:00 AM</pubdate>
    </item>
    <item>
      <title>Chimerix Completes Phase I Study And Initiates A PHASE II Multi-Dose Clinical Trial For CMX001</title>
      <description>Chimerix, Inc., a biotechnology company
developing orally available antiviral therapeutics, announced recently that the Company has
completed a single and multi-dose Phase I study of CMX001 in healthy volunteers.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Chimerix-Completes-Phase-I-Study-And-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 2:56:00 AM</pubdate>
    </item>
    <item>
      <title>Protein's Essential Role In Repairing Damaged Cells Revealed</title>
      <description>University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Proteins-Essential-Role-In-Repairing-Damaged-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 2:46:00 AM</pubdate>
    </item>
    <item>
      <title>Sangamo Biosciences Announces License Agreement With Pfizer For Zinc Finger Nucleases For Protein Production</title>
      <description>Sangamo BioSciences, Inc. , the leading developer of zinc finger DNA-binding proteins (ZFPs), recently announced an agreement to provide Pfizer Inc with a worldwide, non-exclusive license for the use of certain ZFP Nuclease (ZFNs) reagents to permanently eliminate the Glutamine Synthetase (GS) gene in Chinese Hamster Ovary (CHO) cell lines and for the use of these ZFN-modified cells for clinical and commercial production of therapeutic proteins. </description>
      <link>http://www.bioresearchonline.com/article.mvc/Sangamo-Biosciences-Announces-License-0002?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 2:40:00 AM</pubdate>
    </item>
    <item>
      <title>GeneGo Renews Its Agreement With Bayer Schering Pharma AG For Another Three Years </title>
      <description>GeneGo, Inc., a leading provider of software and high quality manually curated databases for systems biology and pathway analysis, recently announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years.</description>
      <link>http://www.bioresearchonline.com/article.mvc/GeneGo-Renews-Its-Agreement-With-Bayer-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 1:28:00 AM</pubdate>
    </item>
    <item>
      <title>BASi Receives A European Patent For Cultex&amp;reg;</title>
      <description>BASi is proud to announce the awarding of the new European patent for their Culex&amp;reg; Automated In Vivo Sampling System. The patent is valid until 2019 and is effective in Germany, Denmark, France, UK and Sweden.</description>
      <link>http://www.bioresearchonline.com/article.mvc/BASi-Receives-A-European-Patent-For-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/6/2009 1:28:00 AM</pubdate>
    </item>
    <item>
      <title>RainDance Technologies And Harvard University To Share In First Massachusetts Life Sciences Center Cooperative Research Grants </title>
      <description>RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, recently announced that it has been selected to share in the first-ever round of cooperative research grants by The Massachusetts Life Sciences Center (MLSC).</description>
      <link>http://www.bioresearchonline.com/article.mvc/Raindance-Technologies-And-Harvard-University-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 4:48:00 AM</pubdate>
    </item>
    <item>
      <title>Testes Stem Cell Can Change Into Other Body Tissues, Stanford/UCSF Study Shows</title>
      <description>Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Testes-Stem-Cell-Can-Change-Into-Other-Body-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 2:54:00 AM</pubdate>
    </item>
    <item>
      <title>Collagen VI May Help Protect The Brain Against Alzheimer's Disease</title>
      <description>Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aß) proteins, which are widely thought to cause Alzheimer's disease (AD). </description>
      <link>http://www.bioresearchonline.com/article.mvc/Collagen-VI-May-Help-Protect-The-Brain-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 2:40:00 AM</pubdate>
    </item>
    <item>
      <title>Cell Biologists Identify New Tumor Suppressor For Lung Cancer</title>
      <description>Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Cell-Biologists-Identify-New-Tumor-Suppressor-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 2:32:00 AM</pubdate>
    </item>
    <item>
      <title>NanoInk Launches NanoStem Cell Division</title>
      <description>NanoInk, Inc., a global leader in nanotechnology, began the new year by announcing the launch of its NanoStem Cell division.</description>
      <link>http://www.bioresearchonline.com/article.mvc/NanoInk-Launches-NanoStem-Cell-Division-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 2:32:00 AM</pubdate>
    </item>
    <item>
      <title>'Relocation' Plan Of Metastatic Cancer Cells Uncovered By Stanford Researchers</title>
      <description>Few things are as tiresome as house hunting and moving. Unfortunately, metastatic cancer cells have the relocation process down pat.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Relocation-Plan-Of-Metastatic-Cancer-Cells-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/5/2009 2:02:00 AM</pubdate>
    </item>
    <item>
      <title>Arizona Instrument LLC Designs Complete Line Of Portable And Fixed Jerome&amp;reg; Toxic Gas Analyzers</title>
      <description>Arizona Instrument LLC, an ISO 9001:2000 registered company, designs, manufactures, and markets the complete line of portable and fixed Jerome® toxic gas analyzers.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Portable-And-Fixed-Jerome-Toxic-Gas-Analyzers-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>1/2/2009 11:01:00 AM</pubdate>
    </item>
    <item>
      <title>Gene Therapy Reversed Heart Damage In Heart Failure</title>
      <description>Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine. The study was published online in Circulation.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Gene-Therapy-Reversed-Heart-Damage-In-Heart-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/31/2008 1:26:00 AM</pubdate>
    </item>
    <item>
      <title>Gold Particles Deliver More Than Just Glitter</title>
      <description>Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Gold-Particles-Deliver-More-Than-Just-Glitter-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/30/2008 3:51:00 AM</pubdate>
    </item>
    <item>
      <title>Study Links Molecule To Muscle Maturation, Muscle Cancer</title>
      <description>Researchers at The Ohio State University Comprehensive Cancer Center have discovered that a molecule implicated in leukemia and lung cancer is also important in muscle repair and in a muscle cancer that strikes mainly children.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Study-Links-Molecule-To-Muscle-Maturation-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/30/2008 3:39:00 AM</pubdate>
    </item>
    <item>
      <title>Safe New Therapy For Genetic Heart Disease, Clinical Trial Suggests</title>
      <description>A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Safe-New-Therapy-For-Genetic-Heart-Disease-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/30/2008 3:14:00 AM</pubdate>
    </item>
    <item>
      <title>Nanotechnology May Be Used For Food Safety</title>
      <description>A microscopic biological sensor that detects Salmonella bacteria in lab tests has been developed by an Agricultural Research Service (ARS) scientist and university colleagues. The sensor could be adapted to detect other foodborne pathogens as well.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Nanotechnology-May-Be-Used-For-Food-Safety-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/30/2008 1:19:00 AM</pubdate>
    </item>
    <item>
      <title>Both Major Theories About Human Cellular Aging Supported By New Research</title>
      <description>Aging yeast cells accumulate damage over time, but they do so by following a pattern laid down earlier in their life by diet as well as the genes that control metabolism and the dynamics of cell structures such as mitochondria, the power plants of cells.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Both-Major-Theories-About-Human-Cellular-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubdate>12/30/2008 12:59:00 AM</pubdate>
    </item>
  </channel>
</rss>